Article Information
History
- February 9, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Deborah Cromer1,*,
- Arnold Reynaldi1,
- Ainslie Hie1,
- Timothy E. Schlub1,2,
- Jennifer A. Juno3,
- Adam K. Wheatley3,
- Stephen J. Kent3,4,
- David S. Khoury1 and
- Miles P. Davenport1
- 1Kirby Institute, University of New South Wales, Sydney, Australia
- 2Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
- 3Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
- 4Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia
- ↵*Corresponding author; email: d.cromer{at}unsw.edu.au
Posted February 09, 2024.
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
6
Blogs/Media
Author Videos